Phoenix friends at Translational Software have released a white paper on the importance of pharmacogenetic testing in improving health care. While the payer and regulatory landscapes are shifting, as insurance companies and bureaucrats try to develop ways to manage this new service, patients are very clearly interested in understanding and taking control of their own health and are ready NOW.
Translational's white paper dives into the benefits of pharmacogenetic testing, the barriers to entry for labs looking to capitalize on the wave of Personalized Medicine, and how much an organization can benefit by outsourcing the most difficult aspect of testing--the interpretive report.
Phoenix has been there. We've built reports from scratch, built even bigger reports with automated systems, and helped build even more complex reports than that. It's no easy task and requires highly qualified individuals and a whole lot of time and dedication. If you're not prepared to take that on (and who wants to reinvent the wheel, anyway?) your best bet is to outsource. The benefits are many, the drawbacks few to none.
Check it out!
Translational's white paper dives into the benefits of pharmacogenetic testing, the barriers to entry for labs looking to capitalize on the wave of Personalized Medicine, and how much an organization can benefit by outsourcing the most difficult aspect of testing--the interpretive report.
Phoenix has been there. We've built reports from scratch, built even bigger reports with automated systems, and helped build even more complex reports than that. It's no easy task and requires highly qualified individuals and a whole lot of time and dedication. If you're not prepared to take that on (and who wants to reinvent the wheel, anyway?) your best bet is to outsource. The benefits are many, the drawbacks few to none.
Check it out!
RSS Feed
